Skip to content

Change in AR at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$212.05M+8,382%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$65.78M-40.5%
TG Therapeutics logo
TG TherapeuticsTGTX
$86.42M+41.8%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$81.4M+121%
Exelixis logo
ExelixisEXEL
$42.03M+161%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM

Other financials

Income statement

See full
Revenue$60.1M+83.8%
Gross profit$53.0M+82.3%
Operating income-$52.4M-11.4%
Net income-$55.6M-12.4%
EPS (diluted)-$0.83-2.5%

Balance sheet

See full
Cash & equivalents$62.1M-41.4%
Total debt$112.3M-1.1%
Total equity$122.9M+549%
Total assets$442.3M+14.4%

Cash flow

See full
Operating cash flow-$44.2M-9.5%
CapEx$238.3K
Free cash flow-$29.2M-2.4%

Valuation

See full
Market cap$6.64B+77.3%
Enterprise value$6.69B+78.4%
P/S30.6×+3.2×

Profitability

See full
Gross margin89.4%-0.2pp
Operating margin-90.9%-19.8pp
Net margin-93.3%-18.2pp
FCF margin-61.5%-14.1pp

Returns & leverage

See full
Return on equity-285.8%-68.9pp
Debt / equity0.9×-5.1×
Current ratio4.2×+0.9×

Where this comes from

Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rhythm Pharmaceuticals, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rhythm Pharmaceuticals, Inc.'s change in AR?
Rhythm Pharmaceuticals, Inc. (RYTM) reported change in AR of $8.11M in Q1 2026.
How has Rhythm Pharmaceuticals, Inc.'s change in AR changed year-over-year?
Rhythm Pharmaceuticals, Inc.'s change in AR increased by 1280.5% year-over-year, from -$687K to $8.11M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.